PMC:7784830 / 7079-7186 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"132","span":{"begin":9,"end":20},"obj":"Chemical"},{"id":"133","span":{"begin":87,"end":106},"obj":"Chemical"}],"attributes":[{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"MESH:C462182"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"MESH:C558899"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, favipiravir appears to be the most potent and promising drug when compared to lopinavir/ritonavir."}

{"project":"LitCovid-sentences","denotations":[{"id":"T60","span":{"begin":0,"end":107},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, favipiravir appears to be the most potent and promising drug when compared to lopinavir/ritonavir."}